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CD28 and T Cell Antigen Receptor Signal 
Transduction Coordinately Regulate Interleukin 2 
Gene Expression In Response to Superantigen 
Stimulation 
By James D. Fraser,* Marianne E. Newton,* and Arthur Weiss*~ 
From the *Howard Hughes Medical Institute; and the CDepartments of Medicine and of 
Microbiology and Immunology, University of California t San Francisco, San Francisco, 
California 94143 
Summary 
Activation of an immune response r quires intercellular contact between T lymphocytes and antigen- 
presenting cells (APC). Interaction of the T cell antigen receptor (TCK) with antigen in the 
context of major histocompatibility molecules mediates signal transduction, but T cell activation 
appears to require the induction of a second costimulatory signal transduction pathway. Recent 
studies uggest that interaction of CD28 with B7 on APC might deliver such a costimulatory 
signal. To investigate he role of CD28 signal transduction during APC-dependent T cell activation, 
we have used Staphylococcal enterotoxins (SEs) presented by a B7-positive APC. We used anti- 
B7 monoclonal ntibodies and a mutant interleukin 2 (II.-2) promoter construct, unresponsive 
to CD28-generated signals, in transient transfection assays to examine the contribution of the 
CD28-B7 interaction to II.-2 gene activation. These studies indicate that the CD28-regnlated 
signal transduction pathway isactivated uring SE stimulation of T cells and plays an important 
role in SE induction of I1.-2 gene expression through its influence upon the CD28-responsive 
element contained within the IL-2 gene promoter. This effect is particularly profound in the 
activation of the IL-2 gene in peripheral blood T cells. 
T lymphocytes are activated by antigen to initiate immune 
responses during a complex interaction with APC. The 
specificity of the T cell response isdetermined by the TCK, 
but interactions with other T cell surface molecules are re- 
quired for activation (1, 2). It is believed that he TCK delivers 
one set of signals, and another receptor delivers asecond signal 
that is required for T cell activation. One candidate for the 
receptor that mediates this second signal is CD28. Treatment 
of T cells with mAb directed against CD28 induces an 
unidentified but distinct signal transduction pathway that syn- 
ergizes with TCR-generated signals to increase mKNA level 
and secretion of several T cell lymphokines, including IL-2, 
GM-CSF, IFN-% I1.-3, TNF-ot, and lymphotoxin (3). CD28 
signal transduction i creases both the rate of IL-2 transcrip- 
tion by activating a specific element of the IL-2 promoter, 
and the stability of the IL-2 mRNA (4, 5). 
A ligand for CD28, B7, has recently been identified (6). 
B7 was first identified on activated B cells and, like CD28, 
is a member of the Ig superfamily (7). Recent studies indi- 
cate that either B7-Ig C3'1 fusion proteins, or B7-transfected 
Chinese hamster ovary cells, can increase proliferation and 
I1.-2 expression from suboptimally activated CD28 + T cells 
(8, 9). These studies uggest that the interaction of CD28 
with B7 can generate a costimulatory signal capable of am- 
plifying T cell lymphokine xpression. 
To investigate he role of CD28 signal transduction during 
APC-dependent activation of the Ib2 gene, we have utilized 
Staphylococcal enterotoxins (SEs) presented by a B7-positive 
APC as a model system. SE's activate T cells by interacting 
with specific variable (V) regions of the TCK/3 chains (10). 
The SEs bind to class II MHC molecules and require the pres- 
ence of class II MHC for efficient activation of T cells (10). 
Using anti-B7 mAbs and a mutant II..2 promoter that is largely 
unresponsive to CD28-generated signals, we have examined 
the contribution of CD28 signal transduction to IL-2 gene 
activation. Our findings indicate that the CD28-regulated 
signal transduction pathway is activated and plays an impor- 
tant role in APC-dependent SE induction of IL-2 gene ex- 
pression. 
Materials and Methods 
Cells. The human leukemic T cell line Jurkat was maintained 
as described (11). Nonadherent PBLs were isolated by density- 
gradient centrifugation through Ficoll-Hypaque (Pharmacia Fine 
Chemicals, Piscataway, NJ) followed by plastic absorption for 2 h 
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at 37~ The PBLs were suspended in RPMI 1640 medium with 
10% FCS, penicillin G, streptomycin (Irvine Scientific, Santa Ana, 
CA), and PHA (100 ng/ml, Burroughs Wellcome, Research Tri- 
angle Park, NC) for 48 h before transfection. 
Immunoprecipitations a d Western Blots. Immunoprecipitates of 
TCR ~ were isolated and resolved on 15% SDS-PAGE gels, trans- 
ferred to nitrocellulose, and analyzed for the presence of hos- 
photyrosine or TCR ~ as described (11). 
Inositol Phosphate Assays. Jurkat cells were loaded with [3H]myo- 
inositol as described (11). The Jurkat ceUs were mixed with either 
mAb anti-Leu4 (1/1,000 dilution of ascites), an equal number of 
Raji cells alone, or Raji ceUs and 100 ng/ml SED (Toxin Technology, 
Madison, WI), and the cells were pelleted to promote call-cell con- 
tact. The cells were cultured for the indicated period of t me at 
37~ in the presence of10 mM LiC1 and then lysed. Soluble ino- 
sitol phosphate generation was determined, as previously de- 
scribed (11). 
Transfections. Jurkat cells were transiently transfected with ei- 
ther plb2-Luc or pM2-Luc using DEAE-Dextran, s previously 
described (12). PBMCs were transfected using electroporation as 
described (13). Transfection ef~ciency was equalized by cotransfecting 
with RSV-CAT. 
Luciferase and Chloramphenicol Acetyltransferase A says. The de- 
termination ofluciferase and chloramphenicol a etyltransferase ac- 
tivity was performed as described (12). 
Results and Discuss ion 
Since there have been conflicting reports regarding the signal 
transduction mechanisms by which "superantigens'~ uch as 
the SEs stimulate T cell activation (14, 15), we attempted 
to characterize the TCtL-generated signal transduction events 
after SE stimulation. The enterotoxin SED, when presented 
by the class II-positive B cell lymphoblastoid l ne Raji, acti- 
Figure 1. The presentation of SE by an APC induces TCR-regulated 
tyrosine kinase activation. Immunoprecipitation and Western blotting of 
the TCR ~ chain. Jurkat cells were incubated with medium (lane 1), 100 
ng/ml SED alone (lane 2), Raji calls alone (lane 3), Raji cells, and 100 
ng/ml SED (lanes 4-7), or with the anti-TCg mAb C305 (lane 8) for 
the indicated times. Immunoprecipitates of the TCR ~ chain were isolated 
and analyzed by Western blot for phosphotyrosine (A) or TCR ~ (B). 
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Figure 2. SE presentation nduces inositol phosphate g neration. Time 
course of total soluble inositol phosphates generation in response toincu- 
bation with Raji alone (A), anti-TCR mAb C305 (R), or Raji and 100 
ng/ml SED (D). Data points represent the mean _+ SD of triplicate samples. 
vates the V38-expressing T cell line Jurkat to secrete IL2 
(16). To determine whether SE-induced IL-2 expression in- 
volves a TCR-activated tyrosine kinase, we stimulated Jurkat 
cells with SED and immunoprecipitated heTCR ~ chain. 
Exposure of Jurkat cells to either Raji or SED cells alone did 
not significantly affect the phosphorylation state of the ~ chain, 
but stimulation with SED plus Raft cells induced rapid and 
prolonged phosphorylation f ~, comparable tothat induced 
by anti-TCR mAb (Fig. 1). 
To investigate whether SED presented by Raft would also 
induce phospholipase C activity, we examined changes in ino- 
sitol phosphate l vels after incubation with either Raji cells 
alone, Raji cells coated with SED, or with anti-TCR mAbs 
(Fig. 2). Treatment of Jurkat cells with anti-TCR antibody 
induced asixfold increase in the level of total inositol phos- 
phates. Whereas incubation with Raji alone failed to induce 
a detectable increase in inositol phosphates, Raji plus SED 
induced a 17-fold increase over thatseen in unstimulated Jurkat 
after 30 min. By these criteria at least, activation of T cells 
by SE on an APC induces TCIL-generated signals qualita- 
tively similar to that induced by nominal antigen or anti- 
TCK mAbs. 
To determine if interaction of CD28 with B7 is involved 
in the induction of Iio-2 secretion during SED presentation 
to Jurkat, we attempted to block binding of CD28 to B7 
using mAbs directed to B7. Addition of either of two different 
mAbs to B7 decreased the SED-induced IL-2 secretion by 
58-68% (data not shown). 
CD28 stimulation i duces the binding of a nuclear com- 
plex, CD28KC, to an element in the 5' flanking region of 
the IL-2 promoter that is responsible for most of the CD28- 
induced IL2 promoter activity (4). To ascertain whether 
CD28KC activity was induced uring SE stimulation, Jurkat 
cells were transfected with either the plL-2-Luc construct, 
which contains equences from -326 to + 46 of the human 
Ib2 gene directing transcription ofthe firefly luciferase g ne, 
or the pM2-Luc construct, which also includes the -326 
to +46 region of the human II.-2 gene, but contains a4-bp 
substitution i the CD28RE site at -159 to -156 (4). The 
pM2-Luc construct responds to either phorbol 12-myristate 
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Figure 3. The CD28 response element is involved inSED-induced acti- 
vation of the Ib2 gene promoter. Jurkat cells were transiently ransfected 
with either the plb2-Luc (filled bars) or the pM2-Luc plasmids (open bars). 
After 40 h, the transfected Jurkat cells were incubated with Raji alone, 
Raji and 100 ng/ml SED, or Raji cells, 100 ng/ml SED, and mAb B7 
(1:500 dilution of ascites). Data for the pM2-Luc-transfected lls are 
presented as the percent Raft plus SED-induced response ofthe wild-type 
plL2-Luc (mean of 1,118 light U/10 #g). Results represent the mean +_ 
SD of triplicate samples from three independent xperiments. 
13-acetate (PMA) and ionomycin treatment, or anti-TCP,.- 
generated signals, as well as the wild-type plL-2-Luc construct, 
however, CD28-induced activity is decreased by 80-90% (4). 
In Jurkat cells transfected with plL-2-Luc, incubation with 
Raji cells and SED induced a15-25-fold increase in luciferase 
activity compared with cells incubated with Raji alone (Fig. 
3). In contrast, Jurkat transfected with the pM2-Luc con- 
struct responded only 41% as well. Addition of anti-B7 mAb 
caused a62% decrease in the activity induced in the plL-2- 
Luc transfected cells, but only minimally affected the SED- 
induced luciferase activity from the pM2-Luc-transfected cells, 
indicating that the B7 antibody treatment and the enhancer 
mutation were both influencing the same pathway. 
To determine whether CD28 signal transduction also 
affected I1.-2 transcription i peripheral blood T cells, PBLs 
were transfected with either the plL-2-Luc or the pM2-Luc 
constructs, and stimulated with combinations of PMA, 
ionomycin, anti-TCR, and anti-CD28. As seen in the Jurkat 
T cell line, treatment with PMA and ionomycin, or with 
PMA and anti-TCR mAb induced similar levels of luciferase 
activity from either construct (Fig. 4 A). Addition of anti- 
CD28 mAb to PMA and ionomycin-treated cells increased 
the induced luciferase activity by 4.2-fold in the plL2-Luc- 
transfected cells. However, the anti-CD28 treatment only in- 
duced a 1.6-fold increase in the pM2-Luc transfected cells, 
19% of the observed increase for the plL-2-Luc-transfected 
cells. Moreover, treatment ofpM2-Luc-transfected c lls with 
PMA and anti-CD28 mAb induced only 14% of the luciferase 
activity elicited from lymphocytes transfected with the wild- 
type pll~2-Luc plasmid. Thus, the comparison of the activity 
of the wild-type plL-2-Luc to the activity of pM2-Luc con- 
taining the 4-bp mutation of the CD28 responsive lement 
reveals a specific target of the CD28 signal transduction 
pathway in normal T cells, as was previously detected in Jurkat. 
Activation of normal peripheral T lymphocytes is strin- 
gently regulated, perhaps more so than might be observed 
with the leukemic T cell line such as Jurkat. To assess the 
role of CD28 signal transduction i APC-de~endent SE- 
A 
Treatment 
PMA + [ono. 
PMA + Iono. 
+ anli-CD28 
PMA + anlti-Cl)3 
PMA + anfi-CD28 
B 
Treatment 
Group 1 
1 7  ~ Group 2 
Group 3 
Group 3+anti-B7 
i 
100 200 300 400 500 
Percent Activity 
tlmmmam 
1 t 
0 50 100 
Percent Activity 
Figure 4. CD28 stimulation increases II.-2 promoter activity in peripheral blood T cells, and the CD28 signal transduction pathway is used uring 
SE-induced IL-2 gene activation. Peripheral b ood T cells were transfected with either the plD2-Luc (filled bars) or the pM2-Luc plasmids (open Mrs). 
(,4) The transfected T cells were stimulated with the indicated combinations of PMA (5 ng/ml), ionomycin (1#M), anti-CD3 (anti-Leu 4,100 ng/ml), 
and anti-CD28 (9.3, 100 ng/ml). The results are presented as the percent response ofthe PMA- and ionomycin-induced plL-2-Luc-transfected ells
(mean of 12,178 light U/10 #g). (B) The transfected T cells were incubated with Raji cells and 100 ng/ml each SED, TSST, and SEC2 (Group 1), 
Raji, and 100 ng/ml each of SEA, SEB, and SEC3 (Group 2), or Raji and 100 ng/ml each of SEA, SEB, and SEE (Group 3) for 8 h. Anti-B7 antibody 
was used at a 1:500 dilution of ascites. Data for the pM2-Luc-transfected ells are presented as the percent response ofthe wild-type plL-2-Luc (mean 
of 6,207 light U/10 #g). Results represent the mean _+ SD of triplicate samples. 
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induced activation of peripheral T cells, mononuclear cells 
transfected with either the plL-2-Luc or the pM2-Luc con- 
structs were stimulated by SE presented on Raji cells. Com- 
binations of SEs were used to stimulate large numbers of T 
cells contained within the polyclonal T cell population. The 
SE-induced luciferase activity from the plL-2-Luc transfected 
lymphocytes ranged from 8 to 26-fold greater than the basal 
activity. In contrast, SE-induced activity in the pM2-Luc- 
transfected T cells was only 11-18% of that of the plL-2-Luc- 
transfected cells (Fig. 4 B). Moreover, the addition of anti- 
B7 antibody caused a 66% decrease in the luciferase activity 
of the plL-2-Luc-transfected cells, but without significantly 
affecting the activity of the pM2-Luc-transfected cells. 
These studies indicate that B7 on the surface of an APC 
can activate CD28 signal transduction a d that this pathway 
contributes substantially tothe induction of IL-2 expression 
in the context of TCR signal transduction. This effect was 
particularly pronounced in peripheral T cells induced by SE 
stimulation. This supports the notion that antigen-induced 
IL-2 gene expression is coordinately regulated by TCR- and 
CD28-generated signals that activate distinct ranscription 
elements. Studies on murine T cell clones indicate that antigen- 
induced proliferation requires activation of a signal transduc- 
tion pathway in addition to those activated via the TCR (1). 
In the absence of this second, or costimulatory signal, the 
T cells fail to secrete IL-2 and enter a prolonged nonrespon- 
sive or anergic state. Whereas the current studies do not 
directly address the role of the CD28 signal transduction i  
preventing induction of the anergic state, they indicate that 
CD28 signal transduction plays an important role in IL-2 gene 
activation and may act as this requisite costimulatory pathway. 
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